Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasushi Fuchimoto, Christene A. Huang, Kazuhiko Yamada, Akira Shimizu, Hiroshi Kitamura, R.B. Colvin, Vincent Ferrara, Michael C. Murphy, Megan Sykes, Mary White-Scharf, David M. Neville Jr., David H. Sachs
Published in Volume 105, Issue 12
J Clin Invest. 2000; 105(12):1779–1789 doi:10.1172/JCI8721
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Peripheral blood T-cell depletion. (a) Absolute number of T cells present in the peripheral blood pretreatment (day –2), and post TI (700 or 1,000 cGy) and pCD3-CRM9 administration (days –1 and 0). (b) Absolute number of T cells remaining in PB on day 0 for each animal.